21 employees
NeoChord is a medical device company that develops devices that allow mitral valve repair to be performed on a beating heart.
2007
$20M
from 5 investors over 5 rounds
NeoChord raised $7M on April 24, 2019
Investors: Treo Ventures
NeoChord raised $20M on June 9, 2015
Investors: COrporacion Hermanos Vazquez S.A de C.V, Hopen Life Sciences, TGap Ventures and Heron Capital